Advertisement

Topics

Takeda Oncology Company Profile

18:36 EDT 16th October 2018 | BioPortfolio

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion for improving the lives of cancer patients. Takeda Oncology was formerly known as Millennium: The Takeda Oncology Company. Additional information about Takeda Oncology is available through its website, www.takedaoncology.com


News Articles [1030 Associated News Articles listed on BioPortfolio]

Shire Rejects Takeda Takeover Bids

Shire said today its board has rejected at least two takeover proposals by Takeda Pharmaceutical, but both companies have confirmed that they remain in talks about a possible acquisition. Shire’...

Shire's $2.4bn oncology sell-off seen as Takeda spoiler

Shire is to sell its oncology business to France’s Servier for $2.4 billion, in a move seen as a deterrent to a takeover by Takeda. The deal works for Servier, which has been trying to build its pr...

Takeda finalises buyout of TiGenix

Japanese pharma giant Takeda has completed its buyout of TiGenix. Takeda’s main R&D focus is in oncology, gastroenterology and neuroscience therapeutic areas, and vaccines. The company employs ...

Takeda’s possible US$50bn Shire bid thrown into doubt as UK pharma sells off oncology unit for US$2.4bn

Takeda is reportedly preparing to launch a bid for Shire before the April 25 deadline, but Shire’s oncology unit was one of the key reasons it wanted the takeover in the first place

Takeda dealmaking continues with new oncology project

California’s Nektar Therapeutics is to collaborate with Tokyo-based Takeda Pharmaceutical over a possible…

Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of ...

– Six Takeda Oncology-Sponsored Abstracts Accepted for Presentation at ASCO 2018 and Eight Abstracts Accepted for Presentation at EHA 2018 – Read more...

Shire's oncology exit weighs on potential Takeda bid

Analysts expect a $2.4 billion deal with Servier to give Shire more negotiating power with Takeda, but it likely won't keep the suitor at bay.

What sparks the investment passions of David Shaywitz of Takeda Ventures? (Q&A)

The Takeda Ventures Senior Partner will take part in the panel discussion Trends in

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Prevacid [Novartis Consumer Health, Inc.]

PREVACID 24 HRLansoprazole delayed-release capsules 15mg / acid reducer

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Lupron depot ped [Takeda Pharmaceutical Company LTD]

LUPRON DEPOT-PED (leuprolide acetate for depot suspension) 7.5 mg, 11.25 mg and 15 mg

Edarbi [Takeda Pharmaceuticals America, Inc.]

These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tabletsInitial U.S. Approval...

Actos [Takeda Pharmaceutical Co LTD]

ACTOS (pioglitazone hydrochloride) Tablets

PubMed Articles [1236 Associated PubMed Articles listed on BioPortfolio]

Measurement of three-dimensional wavefronts using the Ichikawa-Lohmann-Takeda solution to the irradiance transport equation.

In this paper, we use the irradiance transport equation and the Fourier transform-based experimental solution given by Ichikawa-Lohmann-Takeda. We analyze experimental factors such as the digital filt...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Nonspecialty Nurse Education: Evaluation of the Oncology Intensives Initiative, an Oncology Curriculum to Improve Patient Care.

A community hospital combined its medical and surgical patients with cancer on one unit, which resulted in nurses not trained in oncology caring for this patient population.

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

Clinical Trials [541 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Companies [774 Associated Companies listed on BioPortfolio]

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to ...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical de...

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

More Information about "Takeda Oncology" on BioPortfolio

We have published hundreds of Takeda Oncology news stories on BioPortfolio along with dozens of Takeda Oncology Clinical Trials and PubMed Articles about Takeda Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda Oncology Companies in our database. You can also find out about relevant Takeda Oncology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record